| Literature DB >> 34970895 |
Teng Huang1, Rong Shan1, Min Zhang1, Ling Li2, Juan Huang3, Baoan Liu4, Weibing Zhou1.
Abstract
Oncogene StarD4 had the function of promoting proliferation and metastasis of triple-negative breast cancer (TNBC), but its clinical value and molecular mechanism are unknown. This paper found that StarD4 was highly expressed in cancer tissues of TNBC patients, and higher expression level of StarD4 in TNBC patient resulted in poorer prognosis. Based on transcriptomics of MDA-MB-231 cell model, the results of bioinformatics analysis showed that down-regulated expression level of StarD4 led to overall downregulation of cholesterol-relative genes and significant enrichment of cancer mechanism and pathway. Further analysis and investigation verified that StarD4 might cross-promote the protein stability of receptor ITGA5 through the cholesterol pathway to enhance TNBC progression, which provides guidance for clinical application of TNBC diagnosis and treatment.Entities:
Keywords: ITGA5; StarD4; cholesterol metabolism; triple negative breast cancer
Mesh:
Substances:
Year: 2021 PMID: 34970895 DOI: 10.7507/1001-5515.202105008
Source DB: PubMed Journal: Sheng Wu Yi Xue Gong Cheng Xue Za Zhi ISSN: 1001-5515